Skip Navigation


European Heart Journal Advance Access originally published online on November 15, 2007
European Heart Journal 2007 28(24):2957-2959; doi:10.1093/eurheartj/ehm512
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/24/2957    most recent
ehm512v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kasapis, C.
Right arrow Articles by Nallamothu, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasapis, C.
Right arrow Articles by Nallamothu, B. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Use of the electrocardiogram in optimizing reperfusion for ST-elevation myocardial infarction: a new role for an old tool?

Christos Kasapis1,*, and Brahmajee K. Nallamothu1,2

1 Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
2 VA Health Services Research & Development Center of Excellence, Ann Arbor VA Medical Center, Ann Arbor, MI, USA

* Corresponding author. Tel: +1 734 936 8214; fax: +1 734 615 3326.E-mail address: ckasapis@med.umich.edu

This editorial refers to ‘The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy and outcome in the DANAMI-2 trial’ by M.J. Eskola et al., on page 2985

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. Back

The first 150 words of the full text of this article appear below.

Rapidly obtaining an electrocardiogram (ECG) is the critical first step in the evaluation of patients with chest pain. For >25 years, the ECG has been used to detect those patients with ST-elevation myocardial infarction (STEMI) who are eligible for reperfusion therapy with either fibrinolytic therapy or primary percutaneous coronary intervention (PCI).1,2 The ECG also has been instrumental in identifying those patients at highest risk for complications following STEMI and who may gain the most benefit from reperfusion therapy, based on features such as infarct location, the sum of ST-elevations, and the presence of reciprocal ST-depression or arrhythmias.3

Once patients with STEMI are identified, the decision to administer reperfusion therapy should be made as rapidly as possible and, ideally, it should be delivered within 12 h . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial
Markku J. Eskola, Lene Holmvang, Kjell C. Nikus, Samuel Sclarovsky, Hans-Henrik Tilsted, Heini Huhtala, Kari O. Niemelä, and Peter Clemmensen
EHJ 2007 28: 2985-2991. [Abstract] [Full Text]